GURUFOCUS.COM » STOCK LIST » USA » NAS » Illumina Inc (NAS:ILMN) » Definitions » Days Payable
Switch to:

Illumina Days Payable

: 69.67 (As of Mar. 2022)
View and export this data going back to 2000. Start your Free Trial

Illumina's average Accounts Payable for the three months ended in Mar. 2022 was $312 Mil. Illumina's Cost of Goods Sold for the three months ended in Mar. 2022 was $408 Mil. Hence, Illumina's Days Payable for the three months ended in Mar. 2022 was 69.67.

The historical rank and industry rank for Illumina's Days Payable or its related term are showing as below:

ILMN' s Days Payable Range Over the Past 10 Years
Min: 49.95   Med: 59.4   Max: 69.7
Current: 62.79

During the past 13 years, Illumina's highest Days Payable was 69.70. The lowest was 49.95. And the median was 59.40.

ILMN's Days Payable is ranked worse than
50.93% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: 63.98 vs ILMN: 62.79

Illumina's Days Payable increased from Mar. 2021 (51.31) to Mar. 2022 (69.67). It may suggest that Illumina delayed paying its suppliers.


Illumina Days Payable Historical Data

The historical data trend for Illumina's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Days Payable
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.73 60.77 56.48 60.07 69.70

Illumina Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Days Payable Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.31 53.23 60.47 69.27 69.67

Competitive Comparison

For the Diagnostics & Research subindustry, Illumina's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Illumina Days Payable Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Days Payable distribution charts can be found below:

* The bar in red indicates where Illumina's Days Payable falls into.



Illumina Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Illumina's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

Days Payable (A: Dec. 2021 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2020 ) + Accounts Payable (A: Dec. 2021 )) / count ) / Cost of Goods Sold (A: Dec. 2021 )*Days in Period
=( (192 + 332) / 2 ) / 1372*365
=262 / 1372*365
=69.70

Illumina's Days Payable for the quarter that ended in Mar. 2022 is calculated as:

Days Payable (Q: Mar. 2022 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2021 ) + Accounts Payable (Q: Mar. 2022 )) / count ) / Cost of Goods Sold (Q: Mar. 2022 )*Days in Period
=( (332 + 291) / 2 ) / 408*365 / 4
=311.5 / 408*365 / 4
=69.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Illumina Days Payable Related Terms

Thank you for viewing the detailed overview of Illumina's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina Business Description

Illumina logo
Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
Executives
Frank John Edward officer: Chief Public Affairs Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Rollins Carissa officer: SVP, Chief Information Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Pegels Kevin Carl officer: Chief of Global Operations 5200 ILLUMINA WAY SAN DIEGO CA 92122
Torres Jose officer: VP, Chief Accounting Officer 1300 W. 120TH AVENUE WESTMINSTER CO 80234
Reeves Kathryne Gambrell officer: SVP, Chief Marketing Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Aravanis Alexander officer: SVP, Chief Technology Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Gottlieb Scott director MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142
Febbo Phillip G. officer: SVP Chief Medical Officer C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Tousi Susan H officer: SVP Product Development 5200 ILLUMINA WAY SAN DIEGO CA 92122
Goswami Joydeep officer: SVP Corp Business Development SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023
Siegel Susan E director 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025
Ragusa Robert P officer: SVP, Global Quality & Ops
Hoyt Aimee L officer: SVP, Chief People Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Guthart Gary S director C/O INTUITIVE SURGICAL INC 1266 KIFER RD SUNNYVALE CA 94086
Mcginnis Karen K officer: VP, Chief Accounting Officer INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284

Illumina Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)